-
公开(公告)号:US20160324243A1
公开(公告)日:2016-11-10
申请号:US15215258
申请日:2016-07-20
申请人: Davis Graham Jackson
发明人: Davis Graham Jackson
IPC分类号: A41G7/00
CPC分类号: A41G7/00
摘要: An apparatus for holding a mask on a user utilizes a head piece which the user dons over at least part of the face and which supports a separate mask such a Halloween mask to hold the mask in position relative to the eyes of the user
摘要翻译: 用于在使用者上握持面具的装置利用使用者在脸部的至少一部分上方的头部,并且支撑单独的面具,例如万圣节面具,以将面罩相对于使用者的眼睛保持就位
-
公开(公告)号:US08431526B2
公开(公告)日:2013-04-30
申请号:US13221417
申请日:2011-08-30
IPC分类号: C07K14/00
CPC分类号: A61L2/16 , A01N37/16 , A23L3/3499 , A23L3/3508 , A23L3/3571 , A61L2/186 , A61L2202/24 , C11D3/386 , C11D3/3947 , C11D3/48 , C11D11/0041 , A01N2300/00 , A01N25/30 , A01N37/46 , A01N61/00 , A01N63/00 , A01N63/02 , A01N63/04 , A01N65/00
摘要: The invention relates to compositions and methods for prion degradation, decontamination or disinfection. The composition comprises an oxidizing agent, one or more proteases and a surfactant such as an ionic surfactant/detergent. The method comprises contacting a prion contaminated entity with a prion-degrading composition comprising an effective amount of an oxidizing agent, an effective amount of at least one protease, and an effective amount of a surfactant. The components of the composition may be contacted with a prion-contaminated entity sequentially or simultaneously using an aqueous composition. Typically at least two different proteases are used for optimal efficacy. Preferably the oxidizing agent comprises peracetyl ions or a source thereof. The invention also relates to kits comprising the various reagents.
摘要翻译: 本发明涉及朊病毒降解,去污或消毒的组合物和方法。 组合物包含氧化剂,一种或多种蛋白酶和表面活性剂如离子表面活性剂/洗涤剂。 该方法包括使朊病毒污染的实体与包含有效量的氧化剂,有效量的至少一种蛋白酶和有效量的表面活性剂的朊病毒降解组合物接触。 组合物的组分可以使用水性组合物依次或同时与朊病毒污染的实体接触。 通常使用至少两种不同的蛋白酶来获得最佳疗效。 优选地,氧化剂包括全乙酰离子或其源。 本发明还涉及包含各种试剂的试剂盒。
-
公开(公告)号:US07662407B2
公开(公告)日:2010-02-16
申请号:US11766251
申请日:2007-06-21
IPC分类号: A61K9/54 , A61K9/22 , A61K31/135
CPC分类号: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
摘要翻译: 本发明涉及包含安非他酮盐的药物组合物,制剂和药物,特别是包含有效量的安非他酮氢溴酸盐的改性释放片剂,以及使用安非他酮盐来制备治疗病症的药物。
-
公开(公告)号:US20090004281A1
公开(公告)日:2009-01-01
申请号:US11768764
申请日:2007-06-26
申请人: Tien Nghiem , Graham JACKSON
发明人: Tien Nghiem , Graham JACKSON
IPC分类号: A61K9/50 , A61K31/27 , A61K31/428 , A61P25/16 , A61P9/06 , A61P25/28 , A61P25/00 , A61K31/554
CPC分类号: A61K31/428 , A61K9/0004 , A61K31/27 , A61K31/554
摘要: The present invention relates to a multiparticulate osmotic delivery system. The system is a modified release composition suitable for oral administration. The composition includes a core that includes at least one drug in combination with at least one pharmaceutically acceptable excipient. The composition further includes an osmotic subcoat surrounding the core, and a modified release overcoat surrounding the osmotic subcoated core.
摘要翻译: 本发明涉及多颗粒渗透递送系统。 该系统是适于口服给药的改良释放组合物。 组合物包括与至少一种药学上可接受的赋形剂组合的至少一种药物的核心。 组合物还包括围绕芯的渗透性底涂层和围绕渗透性底涂芯的改性释放外涂层。
-
公开(公告)号:US20080206843A1
公开(公告)日:2008-08-28
申请号:US11977844
申请日:2007-10-26
IPC分类号: C11D7/42
CPC分类号: A61L2/16 , A01N37/16 , A23L3/3499 , A23L3/3508 , A23L3/3571 , A61L2/186 , A61L2202/24 , C11D3/386 , C11D3/3947 , C11D3/48 , C11D11/0041 , A01N2300/00 , A01N25/30 , A01N37/46 , A01N61/00 , A01N63/00 , A01N63/02 , A01N63/04 , A01N65/00
摘要: The invention relates to compositions and methods for prion degradation, decontamination or disinfection. The composition comprises an oxidizing agent, one or more proteases and a surfactant such as an ionic surfactant/detergent. The method comprises contacting a prion contaminated entity with a prion-degrading composition comprising an effective amount of an oxidizing agent, an effective amount of at least one protease, and an effective amount of a surfactant. The components of the composition may be contacted with a prion-contaminated entity sequentially or simultaneously using an aqueous composition. Typically at least two different proteases are used for optimal efficacy. Preferably the oxidizing agent comprises peracetyl ions or a source thereof. The invention also relates to kits comprising the various reagents.
摘要翻译: 本发明涉及朊病毒降解,去污或消毒的组合物和方法。 组合物包含氧化剂,一种或多种蛋白酶和表面活性剂如离子表面活性剂/洗涤剂。 该方法包括使朊病毒污染的实体与包含有效量的氧化剂,有效量的至少一种蛋白酶和有效量的表面活性剂的朊病毒降解组合物接触。 组合物的组分可以使用水性组合物依次或同时与朊病毒污染的实体接触。 通常使用至少两种不同的蛋白酶来获得最佳疗效。 优选地,氧化剂包括全乙酰离子或其源。 本发明还涉及包含各种试剂的试剂盒。
-
公开(公告)号:US20080141581A1
公开(公告)日:2008-06-19
申请号:US11946427
申请日:2007-11-28
IPC分类号: C10L1/188
CPC分类号: C10L1/22 , C10L1/143 , C10L1/1973 , C10L1/221 , C10L1/224 , C10L1/226 , C10L1/238 , C10L1/2381 , C10L1/2383 , C10L10/14
摘要: A fuel oil composition is disclosed. The fuel oil includes a major proportion of a fuel oil and minor amounts of: (a) at least one polar nitrogen compound effective as a max anti-settling additive; and (b) at least one reaction product between a hydrocarbayl-substituted succinic acid or anhydride and hydrazine.
摘要翻译: 公开了一种燃料油组合物。 燃料油包括燃料油的主要部分和少量的:(a)至少一种作为最大抗沉降添加剂有效的极性氮化合物; 和(b)在烃取代的琥珀酸或酸酐与肼之间的至少一种反应产物。
-
公开(公告)号:US20080141579A1
公开(公告)日:2008-06-19
申请号:US11946394
申请日:2007-11-28
IPC分类号: C10L1/188
CPC分类号: C10L1/143 , C10L1/1881 , C10L1/1883 , C10L1/1888 , C10L1/189 , C10L1/198 , C10L1/221 , C10L1/224 , C10L1/2383 , C10L10/14 , C10L10/16
摘要: A method of improving the low temperature properties of a fuel oil and minor amounts of (a) at least one polar nitrogen compound effective and (b) at least one polyamine detergent is disclosed. The method involves adding to the composition (c) at least one acidic organic species.
摘要翻译: 公开了一种改善燃料油的低温性能和少量(a)至少一种有效的至少一种极性氮化合物和(b)至少一种多胺洗涤剂的方法。 该方法包括向组合物(c)中加入至少一种酸性有机物质。
-
公开(公告)号:US20080138404A1
公开(公告)日:2008-06-12
申请号:US11945422
申请日:2007-11-27
申请人: Edwin WALSH , Ann Marie YOUNG , Graham JACKSON
发明人: Edwin WALSH , Ann Marie YOUNG , Graham JACKSON
IPC分类号: A61K9/22 , A61K31/403 , A61K9/52
CPC分类号: A61K31/403 , A61K9/2031
摘要: An improved controlled release dosage form for once-daily administration of carvedilol is described. The controlled release dosage form comprises a therapeutically effective amount of carvedilol and/or a pharmaceutically acceptable salt thereof; one or more hydrophilic polymers; one or more pharmaceutically acceptable excipients; and a polyoxyalkylene block copolymer, a solid dispersion of carvedilol and an extrusion material or a combination of a polyoxyalkylene block copolymer, a solid dispersion of carvedilol and an extrusion material.
摘要翻译: 描述了一种每日一次给予卡维地洛的改进的控释剂型。 控释剂型包含治疗有效量的卡维地洛和/或其药学上可接受的盐; 一种或多种亲水聚合物; 一种或多种药学上可接受的赋形剂; 和聚氧化烯嵌段共聚物,卡维地洛的固体分散体和挤出材料或聚氧化烯嵌段共聚物,卡维地洛的固体分散体和挤出材料的组合。
-
公开(公告)号:US20080051606A1
公开(公告)日:2008-02-28
申请号:US11755946
申请日:2007-05-31
申请人: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
发明人: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
IPC分类号: C07C211/27
CPC分类号: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号:US20080038348A1
公开(公告)日:2008-02-14
申请号:US11762343
申请日:2007-06-13
申请人: Werner OBEREGGER , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty Saleh
发明人: Werner OBEREGGER , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty Saleh
IPC分类号: A61K9/24 , A61K31/135 , A61P25/00
CPC分类号: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
摘要: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
-
-
-
-
-
-
-
-